Low-dose aspirin for early COVID-19: does the early bird catch the worm?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose aspirin for early COVID-19: does the early bird catch the worm?

Published:2021-07-12 Issue: Volume: Page:1-4
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Rizk John G.¹^ORCID,Lavie Carl J.²^ORCID,Gupta Ajay³

Affiliation:

1. Arizona State University, Edson College, Phoenix, AZ, USA

2. John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA, USA

3. Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine, School of Medicine, Irvine, CA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1950687

Reference30 articles.

1. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

2. Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”

3. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy

4. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series

5. Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Chinese herbal medicine to prevent and treat COVID-19 household close contacts in Hong Kong: an open-label, randomized controlled trial;Frontiers in Immunology;2024-05-10

2. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection;Expert Review of Hematology;2023-11-28

3. Aspirin inhibits rotavirus replication and alters rat gut microbial composition;Virology Journal;2023-10-17

4. Impact of COVID-19 pneumonia on pulmonary vascular volume;Frontiers in Medicine;2023-03-22

5. To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years;Seminars in Thrombosis and Hemostasis;2022-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3